Skip to main content
All lobbying filings

W STRATEGIES, LLC

W STRATEGIES, LLC filed a Q2 report for ASTRAZENECA PHARMACEUTICALS LP on July 18, 2025, reporting $80,000 in lobbying income.

Lobbying for ASTRAZENECA PHARMACEUTICALS LP · Biopharmaceutical Company.

All filings by W STRATEGIES, LLC · Everything ASTRAZENECA PHARMACEUTICALS LP has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 18, 2025
Income
$80,000
What the client paid this registrant for the period.
Client based in
Delaware

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Medicare/Medicaid

H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - Orphan Cures Act.

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem